These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 13680113

  • 1. Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration.
    Yagasaki K, Gando S, Matsuda N, Kameue T, Ishitani T, Hirano T, Iseki K.
    Intensive Care Med; 2003 Oct; 29(10):1844-8. PubMed ID: 13680113
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.
    Patel K, Roberts JA, Lipman J, Tett SE, Deldot ME, Kirkpatrick CM.
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5868-73. PubMed ID: 21930888
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of fluconazole in loggerhead sea turtles (Caretta caretta) after single intravenous and subcutaneous injections, and multiple subcutaneous injections.
    Mallo KM, Harms CA, Lewbart GA, Papich MG.
    J Zoo Wildl Med; 2002 Mar; 33(1):29-35. PubMed ID: 12216790
    [Abstract] [Full Text] [Related]

  • 4. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E, Martens T, Iven H, Rob P, Bruch HP.
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients.
    Aoyama T, Hirata K, Hirata R, Yamazaki H, Yamamoto Y, Hayashi H, Matsumoto Y.
    J Clin Pharm Ther; 2012 Jun; 37(3):356-63. PubMed ID: 21883330
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    Fuhrmann V, Schenk P, Jaeger W, Miksits M, Kneidinger N, Warszawska J, Holzinger U, Kitzberger R, Thalhammer F.
    J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.
    Sinnollareddy MG, Roberts JA, Lipman J, Akova M, Bassetti M, De Waele JJ, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Dimopoulos G, DALI Study authors.
    Crit Care; 2015 Feb 04; 19(1):33. PubMed ID: 25888060
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit.
    Rajagopalan P, Pelz RK, Lipsett PA, Swoboda SM, Rinaldi MG, Hendrix CW.
    Pharmacotherapy; 2003 May 04; 23(5):592-602. PubMed ID: 12741433
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of an extended 4-hour infusion of piperacillin-tazobactam in critically ill patients undergoing continuous renal replacement therapy.
    Awissi DK, Beauchamp A, Hébert E, Lavigne V, Munoz DL, Lebrun G, Savoie M, Fagnan M, Amyot J, Tétreault N, Robitaille R, Varin F, Lavallée C, Pichette V, Leblanc M.
    Pharmacotherapy; 2015 Jun 04; 35(6):600-7. PubMed ID: 26095008
    [Abstract] [Full Text] [Related]

  • 16. Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.
    Roger C, Wallis SC, Muller L, Saissi G, Lipman J, Brüggemann RJ, Lefrant JY, Roberts JA.
    Clin Pharmacokinet; 2017 Sep 04; 56(9):1057-1068. PubMed ID: 28035589
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.
    Alobaid AS, Wallis SC, Jarrett P, Starr T, Stuart J, Lassig-Smith M, Mejia JL, Roberts MS, Sinnollareddy MG, Roger C, Lipman J, Roberts JA.
    Antimicrob Agents Chemother; 2016 Nov 04; 60(11):6550-6557. PubMed ID: 27550344
    [Abstract] [Full Text] [Related]

  • 20. Effective fluconazole therapy for liver transplant recipients during continuous hemodiafiltration.
    Kishino S, Koshinami Y, Hosoi T, Suda N, Takekuma Y, Gandoh S, Furukawa H, Todo S, Miyazaki K.
    Ther Drug Monit; 2001 Feb 04; 23(1):4-8. PubMed ID: 11206042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.